Nitrazepam Accord

Nitrazepam, the active ingredient in Nitrazepam Accord, is a benzodiazepine presented as an oral tablet for oral use. It is indicated for the management of insomnia, anxiety disorders, and certain types of epilepsy in adult patients when other therapies are insufficient. It is marketed throughout the European Union and complies with relevant regulatory requirements.

GNH USA supplies Nitrazepam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Nitrazepam, a benzodiazepine, exerts sedative‑hypnotic activity by modulating central nervous system GABAergic transmission, making it useful in several clinical conditions.

- Insomnia: facilitates sleep onset and maintenance, reducing nighttime awakenings in patients with primary or secondary sleep disturbances. - Anxiety disorders: alleviates excessive worry and tension, providing short‑term relief in generalized anxiety or panic episodes. - Epilepsy: serves as an adjunctive therapy for certain seizure types, helping to decrease seizure frequency when other antiepileptics are insufficient.

Nitrazepam may cause a range of adverse reactions, varying from mild to severe, that should be monitored during therapy.

Common Side Effects: - Drowsiness: feeling of sleepiness during the day. - Dizziness: light‑headed sensation, especially when standing quickly. - Fatigue: reduced energy and motivation. - Impaired coordination: clumsiness or difficulty with fine motor tasks. - Memory impairment: short‑term recall difficulties.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that may become life‑threatening. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate care. - Paradoxical reactions: increased agitation, aggression, or hostility. - Dependence and withdrawal: physical reliance with symptoms upon abrupt cessation.

When prescribing nitrazepam, clinicians should consider several precautionary measures to ensure safe use. - Dose adjustment in elderly: start with lower dose due to increased sensitivity. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms. - Use with caution in hepatic impairment: reduced metabolism may increase plasma levels. - Concomitant CNS depressants: avoid or monitor for additive sedation. - Pregnancy and lactation: safety not established; prescribe only if benefits outweigh risks. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Nitrazepam can interact with various medicines, altering its effects or increasing adverse risk.

Major Interactions (Avoid): - Other benzodiazepines: additive central nervous system depression. - Opioids: heightened risk of respiratory depression and profound sedation. - Alcohol: synergistic sedation leading to impaired psychomotor function.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise nitrazepam concentrations. - CYP3A4 inducers (e.g., rifampicin): may lower effectiveness by increasing clearance. - Antidepressants (e.g., SSRIs): can enhance sedative effects.